None listed
Conditions
Interventions
Intervention1: JHB-78: The test product will be applied by the study personnel at all the study visits (day 1 to day 8) and the assessment will carried out after 30 minutes of test product application
Sponsors
ITC Life Sciences & Technology Centre,
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of Indian origin, in the age group of 19-45 years (both ages inclusive). 2. Subject having Normal to dry skin. 3. Subjects with no cuts, abrasions, wounds, injuries, allergies, tattoos, scars, henna or any other developments/artifacts forearms that can impact the measurements. 4. Subjects willing to give a voluntary written informed consent and agree to come for regular follow-up visits as per the scheduled time. 5. Subjects willing to abide by and comply with the study protocol. 6. Subjects willing to not apply any other products on the test site for the duration of the study.
Exclusion criteria
Exclusion criteria: A known history or present condition of allergic response to any cosmetic or fragrance-containing products. 2. Subjects under chronic medication (e.g. aspirin-based products, anti- inflammatories, anti-histamines, corticotherapy, etc.) that might influence the outcome of the study or under Systemic treatment or having Chronic illness (diabetes mellitus, hypertension, liver disease, or history of alcoholism, HIV, hepatitis, etc.,) which may modify the cutaneous state on the day of inclusion or in the previous 30 days. 3. Subjects with wounds, sunburn, scars, tattoos, piercings or a history of intense sun exposure/phototoxicity/allergy at the skin test site(s). 4. Subjects with application of ointments, creams etc. for antibacterial, anti- allergic or immunosuppressive treatment of the skin at the test site(s) 5. Subjects who are pregnant or nursing (as confirmed by Urine pregnancy test for the determination of Pregnancy).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in skin hydration, skin barrier properties and skin Luminance/radiance/ brightness in comparison to the Baseline, Reference product and Controls.Timepoint: Approximately 9 days for each subject excluding screening. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Mukta Sachdev
MS Clinical Research Pvt. Ltd.
Outcome results
None listed